| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2926171 | Hipertensión | 2006 | 9 Pages |
Abstract
BP and MAU decrease with Irbesartan treatment is associated to a decrease in GCR in hypertensive patients. This study also confirms under clinical practice conditions that the benefits on MAU are not only limited to patients with DM but also to the non-diabetics and are constant in the different BMI ranges.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
J. Honorato, F. de Álvaro, C. Calvo, L. Grigorian-Shamagian, I. Parrondo, M.Á. Sánchez-Zamorano, C. Filozof, y grupo KORAL-HTA y grupo KORAL-HTA,